JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
Pembina Pipeline
PBA
$26.7B
| $110M | 0.01% |
3,405,129
+37,274
| +1% | +$1.26M |
2013 Q2
39 quarters
|
|
752
Match Group
MTCH
$9.26B
| $110M | 0.01% |
2,869,331
+829,601
| +41% | +$36.2M |
2015 Q4
29 quarters
|
|
753
iShares MSCI Europe Financials ETF
EUFN
$3.87B
| $110M | 0.01% |
5,870,707
+1,630,224
| +38% | +$31.3M |
2016 Q2
27 quarters
|
|
754
AutoNation
AN
$5.37B
| $110M | 0.01% |
815,658
+36,235
| +5% | +$4.65M |
2013 Q2
39 quarters
|
|
755
Agree Realty
ADC
$8.19B
| $109M | 0.01% |
1,592,060
+400,084
| +34% | +$28.6M |
2013 Q2
39 quarters
|
|
756
National Vision
EYE
$1.3B
| $109M | 0.01% |
5,788,769
-1,881,585
| -25% | -$61.2M |
2017 Q4
21 quarters
|
|
|
APLS
757
DELISTED
Apellis Pharmaceuticals
APLS
| $109M | 0.01% |
1,648,452
-198,857
| -11% | -$11.5M |
2017 Q4
21 quarters
|
|
758
Apollo Global Management
APO
$67.3B
| $108M | 0.01% |
1,715,546
-192,908
| -10% | -$12.9M |
2013 Q2
39 quarters
|
|
759
Cullen/Frost Bankers
CFR
$9.64B
| $108M | 0.01% |
1,027,531
+316,556
| +45% | +$39.4M |
2013 Q2
39 quarters
|
|
760
Clorox
CLX
$9.72B
| $108M | 0.01% |
683,200
-154,712
| -18% | -$23.2M |
2013 Q2
39 quarters
|
|
761
Alcon
ALC
$30.8B
| $107M | 0.01% |
1,519,900
-41,953
| -3% | -$2.99M |
2019 Q2
15 quarters
|
|
762
Warner Bros
WBD
$77.6B
| $107M | 0.01% |
7,085,679
+2,431,698
| +52% | +$34.6M |
2013 Q2
39 quarters
|
|
763
QuidelOrtho
QDEL
$739M
| $107M | 0.01% |
1,200,095
+98,606
| +9% | +$8.58M |
2015 Q3
30 quarters
|
|
764
Restaurant Brands International
QSR
$24.4B
| $107M | 0.01% |
1,590,613
-6,190
| -0.4% | -$403K |
2014 Q4
33 quarters
|
|
765
Banco Santander Chile
BSAC
$15.1B
| $107M | 0.01% |
5,984,977
-7,954
| -0.1% | -$133K |
2013 Q2
39 quarters
|
|
766
CALL
iShares MSCI Australia ETF
EWA
$1.21B
| $107M | 0.01% |
3,893,200
-4,363,400
| -53% | -$102M |
2014 Q3
34 quarters
|
|
767
PUT
State Street Materials Select Sector SPDR ETF
XLB
$7.93B
| $106M | 0.01% |
2,623,200
-6,633,400
| -72% | -$269M |
2014 Q2
35 quarters
|
|
768
Emcor
EME
$34.7B
| $106M | 0.01% |
651,082
+320,153
| +97% | +$49.2M |
2013 Q2
39 quarters
|
|
769
IQVIA
IQV
$42.5B
| $106M | 0.01% |
530,704
+85,531
| +19% | +$18.3M |
2013 Q2
39 quarters
|
|
770
CONMED
CNMD
$1.39B
| $105M | 0.01% |
1,015,245
+101,351
| +11% | +$9.8M |
2013 Q2
39 quarters
|
|
771
GlobalFoundries
GFS
$28B
| $105M | 0.01% |
1,456,712
-148,671
| -9% | -$9.4M |
2021 Q4
5 quarters
|
|
772
Devon Energy
DVN
$52.4B
| $105M | 0.01% |
2,075,704
-551,031
| -21% | -$31.4M |
2013 Q2
39 quarters
|
|
773
Cognex
CGNX
$10.9B
| $105M | 0.01% |
2,119,386
+1,056,834
| +99% | +$53.5M |
2015 Q4
29 quarters
|
|
774
Delta Air Lines
DAL
$55.3B
| $104M | 0.01% |
2,989,289
-3,147,289
| -51% | -$117M |
2013 Q2
39 quarters
|
|
775
Hayward Holdings
HAYW
$2.63B
| $104M | 0.01% |
8,899,941
+1,867,996
| +27% | +$22.9M |
2021 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.